| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.8M | — |
| R&D Expense | $37.5M | +42.3% |
| SG&A Expense | $17.2M | +51.1% |
| Operating Income | -$62.1M | -64.3% |
| Interest Expense | $1.1M | -1.9% |
| Pre-tax Income | -$62.4M | -59.9% |
| Income Tax | $0 | — |
| Net Income | -$62.4M | -59.9% |
| EPS (Basic) | -$1.85 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.1M | +17.4% |
| Accounts Receivable | $2.8M | — |
| Current Assets | $76.7M | -8.0% |
| Total Assets | $78.4M | -8.2% |
| Current Liabilities | $32.0M | +259.4% |
| Long-term Debt | $9.1M | -10.9% |
| Total Liabilities | $46.5M | +145.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.7M | +72.8% |
| Capital Expenditures | $279K | +389.5% |
| Investing Cash Flow | $18.7M | -31.8% |
| Financing Cash Flow | -$1.2M | -103.9% |
| Free Cash Flow | -$9.0M | +72.0% |
| -36.0% |
| EPS (Diluted) | -$1.85 | -36.0% |
| Stockholders' Equity |
| $31.9M |
| -52.0% |